Umbilical-cord MSC reference for ankylosing spondylitis

What to clarify

Ankylosing spondylitis is an inflammatory condition affecting the spine and other sites. Mobility and structural changes are distinct outcomes. A proposed MSC course should identify what is being measured and how ongoing rheumatology care, rehabilitation and medicines will continue.

Before your consultation

Spinal and sacroiliac imaging; mobility and disease-activity measures; current biologic or other medicines; eye or bowel involvement.

Use existing documents for the initial inquiry. The hospital should specify whether additional tests are needed after reviewing them. Arrange secure transfer of records through the care team; do not place sensitive records in a public message.

Evidence and limitations

The supplied price tables identify a named intervention and hospital, but contain no study reference, detailed safety information or patient-specific recommendation. They cannot establish current authorization, benefit, eligibility or availability. Ask for the exact product or cell preparation, the applicable clinical or research pathway and the consent information.

If offered as research, request the registry identifier, study phase, eligibility criteria, sponsor and follow-up obligations. A trial registration is a record of a study; it is not a guarantee that the intervention works.

Questions to ask

Price and quotation

A reference amount is not a total course price. Ask the provider to itemize assessment, testing, cell or product preparation, administration, admission, medicines and follow-up where applicable. Confirm the number of sessions, currency, quote validity and refund or cancellation terms. Accommodation, travel and Uwell coordination are separate unless the written quotation says otherwise.

The hospital-organized source also lists once weekly, three administrations. This is a source note, not scheduling advice.

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

• NIAMS: ankylosing spondylitis
• ClinicalTrials.gov: learn about studies

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Original catalogue entries

• Client catalogue by specialty · row 58
• Client catalogue by hospital · row 16

Source publication date: not supplied. The figures remain source references rather than a current hospital quotation.